Optimi Health CEO buys 3,800 shares in market

Optimi Health Corp., a foreign private issuer, reports that its Chief Executive Officer, Dane Stevens, completed an open market purchase of 3,800 common shares of Optimi Health Corp. at CDN$6.70 per share on August 5, 2026.

Rhea-AI Filing Summary

Optimi Health Corp., a foreign private issuer, reports that its Chief Executive Officer, Dane Stevens, completed an open market purchase of 3,800 common shares of Optimi Health Corp. at CDN$6.70 per share on August 5, 2026. The transaction was executed indirectly through Cathay Visions Enterprises Ltd., a company controlled by Mr. Stevens. Following this purchase, Mr. Stevens beneficially holds 456,347 common shares of Optimi Health Corp., updating the disclosed insider ownership position. The company provided this information in a SEDI Report Statement submitted to securities regulators.

Key Figures

Shares purchased: 3,800 common shares Purchase price per share: CDN$6.70 Beneficial ownership after transaction: 456,347 common shares

3 metrics

Shares purchased 3,800 common shares Open market purchase by CEO Dane Stevens on August 5, 2026

Purchase price per share CDN$6.70 Price paid for 3,800 Optimi Health common shares

Beneficial ownership after transaction 456,347 common shares Shares beneficially held by Dane Stevens following the purchase

Key Terms

foreign private issuer, SEDI Report Statement, open market purchase, beneficially holds

4 terms

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER pursuant to Rule 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

SEDI Report Statement regulatory

"Exhibit 99.1 | | SEDI Report Statement"

open market purchase financial

"reports the open market purchase of 3,800 common shares"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

beneficially holds financial

"Following the transaction, Mr. Stevens beneficially holds 456,347 common shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share purchase did Optimi Health (OPTH) disclose?

Optimi Health reported that CEO Dane Stevens completed an open market purchase of 3,800 common shares at CDN$6.70 per share on August 5, 2026, through Cathay Visions Enterprises Ltd., a company he controls. The transaction was reported as a SEDI Report Statement for U.S. securities regulators.

At what price were Optimi Health (OPTH) shares bought by the CEO?

The shares were purchased at CDN$6.70 per common share. This price applied to the entire block of 3,800 shares acquired by CEO Dane Stevens on August 5, 2026, in an open market transaction executed indirectly through Cathay Visions Enterprises Ltd.

How many Optimi Health (OPTH) shares does CEO Dane Stevens now hold?

Following the reported transaction, Dane Stevens beneficially holds 456,347 common shares of Optimi Health Corp. This figure reflects his updated ownership position after the August 5, 2026 open market purchase carried out through Cathay Visions Enterprises Ltd.

How was the Optimi Health (OPTH) insider transaction structured?

The purchase of 3,800 common shares was made indirectly through Cathay Visions Enterprises Ltd., a company controlled by CEO Dane Stevens. This structure means the shares are held via a controlled entity, while he remains the beneficial owner of the reported holdings.

What regulatory report covers the Optimi Health (OPTH) insider trade?

Optimi Health reported the insider trade in a Form 6-K as a foreign private issuer, with Exhibit 99.1 titled "SEDI Report Statement". That exhibit details the open market purchase and the resulting beneficial ownership of 456,347 common shares by CEO Dane Stevens.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 10:36 AM Accepted by SEC EDGAR 08/07/2026 - 10:35 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-43304

OPTIMI HEALTH CORP.

269 David Brown Way

Princeton, B.C. V0X 1W0

Canada

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒   Form 40-F ☐

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		SEDI Report Statement

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		OPTIMI HEALTH CORP.
Date: August 6, 2026		By:	/s/ Dane Stevens
		Name:	Dane Stevens
		Title:	Chief Executive Officer, Chief Marketing Officer and Director

Exhibit 99.1

Optimi Health Corp. (Nasdaq: OPTH) reports the open market purchase of 3,800 common shares of Optimi Health Corp. at CDN$6.70 by Dane Stevens, Chief Executive Officer of Optimi Health Corp. The purchase was made indirectly through Cathay Visions Enterprises Ltd., a company controlled by Mr. Stevens. on August 5, 2026. Following the transaction, Mr. Stevens beneficially holds 456,347 common shares of Optimi Health Corp.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 822 B